Crisp research and downloads

Digital chatter has accelerated the risk landscape for pharma brands. Our latest survey reveals which risks pharma communications leaders are most concerned about, and how the risk signals embedded within digital chatter can protect their brands from reputational damage.

Corporate leaders are conscious that a wider spectrum of stakeholders—some well intentioned and others not—is originating and amplifying a higher frequency of unpredictable risks online, leading to more crises and having a measurable impact on the bottom line.

Pharma social media activity is rising as brands interact more online with consumers who actively engage in conversations about treatments that impact their health and wellbeing.

Forrester found that Crisp’s actor-centric risk intelligence allows brands to mitigate risk, improve efficiency, and prevent crises based on interviews with four customers as shown in the following three-year risk-adjusted financial analysis.

Forrester found that Crisp’s actor-centric risk intelligence allows brands to mitigate risk, improve efficiency, and prevent crises based on interviews with four customers as shown in the following three-year risk-adjusted financial analysis.

A Forrester study conducted on behalf of Crisp found our customers reduced the impact of a crisis by 40 percent, prevented one-in-three crises per year entirely, and achieved a 572% ROI.